Cooper Companies: Q4 Earnings Insights

Shares of Cooper Companies COO were flat in after-market trading after the company reported Q4 results.

Quarterly Results

Earnings per share fell 4.24% year over year to $3.16, which beat the estimate of $3.09.

Revenue of $681,600,000 decreased by 1.45% from the same period last year, which beat the estimate of $676,200,000.

Looking Ahead

Cooper Companies Sees Q1 Adj. EPS $2.66-$2.86 vs $2.88 Est., Sales $642M-$670M vs $661.75M Est.

Details Of The Call

Date: Dec 03, 2020

Time: 05:00 PM

ET Webcast URL: https://edge.media-server.com/mmc/p/3t9ku6n3

Price Action

Company's 52-week high was at $371.59

52-week low: $236.68

Price action over last quarter: Up 4.48%

Company Overview

Cooper Companies operates two units: CooperVision and CooperSurgical. Accounting for approximately 75% of total sales, CooperVision is the the second-largest player in the oligopolistic contact lens market. Over 50% of CooperVision's sales are in international territories. The second unit, CooperSurgical, develops and manufactures diagnostic and surgical products for gynecologists and obstetricians, including the Paragard IUD, which Cooper acquired from Teva in 2017.